Chimerix Signs Worldwide License Agreement with Merck for CMX157, A Novel Candi - 学术讨论& HBV English

15/10/02说明：此前论坛服务器频繁出错，现已更换服务器。今后论坛继续数据库备份，不备份上传附件。

肝胆相照论坛 › 论坛 › 学术讨论& HBV English › Chimerix Signs Worldwide License Agreement with Merc ...

楼主: StephenW	go Chimerix Signs Worldwide License Agreement with Merck for CMX157, A Novel Candi [复制链接]

Rank: 4

11楼

发表于 2012-8-26 12:56 |只看该作者

对核苷类药物没有信心

回复引用

Rank: 4

12楼

发表于 2012-8-28 09:17 |只看该作者

恩替和提诺已经很不错了。如果得了hbv都没信心，那么多靠核苷维持生命的hiv患者会怎么样？

回复引用

GMT+8, 2024-11-16 20:51 , Processed in 0.011635 second(s), 9 queries , Gzip On.

Powered by Discuz! X1.5

Chimerix Signs Worldwide License Agreement with Merck for CMX157, A Novel Candi [复制链接]